Why is Bliss GVS Pharma falling/rising?

As of 11-Jul, Bliss GVS Pharma Ltd is currently priced at 154.00, reflecting a decrease of 0.25, or 0.16%. The stock has been underperforming, having fallen for the last four consecutive days, resulting in a total decline of 5.52% during this period. Additionally, the stock's performance today has underperformed its sector by 0.74%. While the stock has generated a return of 32.30% over the past year, it has also seen a significant drop in profits by 19.5%. The company maintains a low debt-to-equity ratio and is trading at a fair valuation compared to its peers, which suggests that despite recent declines, the stock may still be considered a hold.
In the broader market context, the stock's short-term performance has been less favorable compared to the benchmark, with a 1-week return of -1.50% against the Sensex's -1.12%. Over the past month, however, Bliss GVS Pharma has outperformed the benchmark with a return of 0.92% compared to the Sensex's -0.02%. Despite the recent downturn, the stock has shown strong long-term performance, outperforming the BSE500 over the last three years, one year, and three months, indicating that while there are current challenges, the overall trajectory remains positive in the long term.